Jim Frates

Jim Frates

Director of Finance/CFO bij AMYLYX PHARMACEUTICALS, INC.

Vermogen: 770 401 $ op 31-03-2024

56 jaar
Consumer Services
Commercial Services
Health Technology

Profiel

James M.
Frates
is currently the Director at St. Francis House, Independent Director at SAGE Therapeutics, Inc., and Chief Financial Officer at Amylyx Pharmaceuticals, Inc. He previously worked as the Director at GPC Biotech AG and National Director at The Association of Bioscience Financial Officers.
He was also the Vice President-Investment Banking at Robertson Stephens & Co. and the Chief Financial Officer & Senior Vice President at Alkermes Plc.
Frates has served as Treasurer & Trustee at St. Paul's School and Roxbury Latin School.
Frates holds an MBA degree from Harvard Business School and an undergraduate degree from Harvard College.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
16-04-2024 252 495 ( 0.37% ) 717 086 $ 31-03-2024
03-01-2024 2 845 ( 0.00% ) 53 315 $ 31-03-2024

Actieve functies van Jim Frates

BedrijvenFunctieBegin
SAGE THERAPEUTICS, INC. Director/Board Member 10-06-2014
AMYLYX PHARMACEUTICALS, INC. Director of Finance/CFO 01-01-2021
Director/Board Member -
Alle actieve functies van Jim Frates

Eerdere bekende functies van Jim Frates

BedrijvenFunctieEinde
ALKERMES PLC Director of Finance/CFO 11-01-2021
Director/Board Member 01-06-2009
Director/Board Member 01-01-2009
Robertson Stephens & Co. Corporate Officer/Principal 01-06-1998
Roxbury Latin School Director/Board Member -
Ervaring van Jim Frates in detail bekijken

Opleiding van Jim Frates

Harvard Business School Masters Business Admin
Harvard College Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Jim Frates in detail bekijken

Connecties

98

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
SAGE THERAPEUTICS, INC.

Health Technology

AMYLYX PHARMACEUTICALS, INC.

Health Technology

ALKERMES PLC

Health Technology

Bedrijven in privébezit4

Commercial Services

Robertson Stephens & Co.

Finance

Commercial Services

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Jim Frates